Phase 1 Prospective Study of Markers of Ovarian Reserve in Young Female Cancer Patients
N/A
5 Years
45 Years
5 Years
45 Years
Open (Enrolling)
Female
Infertility
Female
Infertility
Trial Information
Phase 1 Prospective Study of Markers of Ovarian Reserve in Young Female Cancer Patients
our objective is to prospectively follow patients before and after their cancer treatment.
this should help us learn of the gonadotoxicity of various treatments as well as be able to
better consult these and future patients of the need of fertility preservation techniques.
Inclusion Criteria:
- all females prior and after chemotherapy
Exclusion Criteria:
- do not consent
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Outcome Measure:
Anti mullerian hormone
Outcome Time Frame:
2 years
Safety Issue:
No
Authority:
United States: Institutional Review Board
Study ID:
111222
NCT ID:
NCT00930501
Start Date:
June 2009
Completion Date:
December 2013
Related Keywords:
- Infertility
- chemotherapy
- cancer
- AMH
- gonadotoxicity
- ovarian reserve
- patients exposed to chemotherapy
- Infertility
Name | Location |
|---|
